Caspofungin in combination with amphotericin B against Candida glabrata

Antimicrob Agents Chemother. 2005 Jun;49(6):2546-9. doi: 10.1128/AAC.49.6.2546-2549.2005.

Abstract

The effects of caspofungin combined with amphotericin B were investigated with Candida glabrata. Although in vitro experiments showed an indifferent interaction, the combination regimen was the only therapeutic approach yielding organ sterilization in a murine candidemia model.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / pharmacology
  • Amphotericin B / therapeutic use*
  • Animals
  • Antifungal Agents / pharmacology
  • Antifungal Agents / therapeutic use*
  • Candida glabrata / drug effects*
  • Candida glabrata / growth & development
  • Candidiasis / drug therapy*
  • Candidiasis / microbiology
  • Caspofungin
  • Colony Count, Microbial
  • Drug Therapy, Combination
  • Echinocandins
  • Fungemia / drug therapy*
  • Fungemia / microbiology
  • Lipopeptides
  • Male
  • Mice
  • Microbial Sensitivity Tests / methods
  • Peptides, Cyclic / pharmacology
  • Peptides, Cyclic / therapeutic use*
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • Peptides, Cyclic
  • Amphotericin B
  • Caspofungin